BURLINGTON, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Cardurion Pharmaceuticals, Inc. (鈥淐ardurion鈥� or 鈥渢he Company鈥�), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today ...
MANASSAS, Va.--(BUSINESS WIRE)--Nov 7, 2023--<a ...
PRINCETON, N.J.--(BUSINESS WIRE)--Nov 7, 2023--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2023 financial results on November ...
MONTVALE, N.J., Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key ...
WALTHAM, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management ...
WASHINGTON (AP) 鈥� As U.S. doctors scale back their use of <a href="https://apnews.com/article/opioids-distribution-prescription-data-us-overdose-crisis-8bb8d2138fb51289b0189e4af250da12">opioid painkillers</a>, a new option for hard-to-treat pain is taking root: ...